Skip to main navigation Skip to search Skip to main content

Imaging-guided percutaneous splenic biopsy using a 20- or 22-gauge cutting-edge core biopsy needle for the diagnosis of malignant lymphoma

  • Sivan Lieberman*
  • , Eugene Libson
  • , Bella Maly
  • , Pinchas Lebensart
  • , Dina Ben-Yehuda
  • , Allan I. Bloom
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Abstract

OBJECTIVE. We estimated the accuracy and safety of imaging-guided needle biopsy for the diagnosis of suspected malignant lymphoma in patients with a splenic lesion. CONCLUSION. Imaging-guided small-bore cutting-edge needle biopsy of splenic lesions is a safe procedure. In most patients with primary or recurrent lymphoma, the disease subtype can be diagnosed reliably.

Original languageEnglish
Pages (from-to)1025-1027
Number of pages3
JournalAmerican Journal of Roentgenology
Volume181
Issue number4
DOIs
StatePublished - 1 Oct 2003
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Imaging-guided percutaneous splenic biopsy using a 20- or 22-gauge cutting-edge core biopsy needle for the diagnosis of malignant lymphoma'. Together they form a unique fingerprint.

Cite this